KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Return on Invested Capital (2016 - 2026)

Evolent Health has reported Return on Invested Capital over the past 11 years, most recently at 0.01% for Q4 2025.

  • For Q4 2025, Return on Invested Capital fell 1.0% year-over-year to 0.01%; the TTM value through Dec 2025 reached 0.01%, down 1.0%, while the annual FY2025 figure was 0.01%, 0.0% changed from the prior year.
  • Return on Invested Capital for Q4 2025 was 0.01% at Evolent Health, down from 0.0% in the prior quarter.
  • Over five years, Return on Invested Capital peaked at 0.0% in Q4 2022 and troughed at 0.01% in Q4 2025.
  • A 5-year average of 0.0% and a median of 0.0% in 2024 define the central range for Return on Invested Capital.
  • Biggest five-year swings in Return on Invested Capital: grew 1bps in 2021 and later fell -1bps in 2025.
  • Year by year, Return on Invested Capital stood at 0.0% in 2021, then surged by 102bps to 0.0% in 2022, then plummeted by -2979bps to 0.0% in 2023, then rose by 2bps to 0.0% in 2024, then tumbled by -1713bps to 0.01% in 2025.
  • Business Quant data shows Return on Invested Capital for EVH at 0.01% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.